Armand González‐Escalante

Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease

Marta Milà‐Alomà, Nicholas J. Ashton, Mahnaz Shekari et al. · Nature Medicine · 2022 · 341 citations · Full text

A novel ultrasensitive assay for plasma p‐tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease

Fernando González‐Ortiz, Pâmela C.L. Ferreira, Armand González‐Escalante et al. · Alzheimer s & Dementia · 2023 · 81 citations · Full text

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability

Joseph Therriault, Shorena Janelidze, Andréa Lessa Benedet et al. · Nature Aging · 2024 · 70 citations · Full text

Genetic characterization of the ALFA study: Uncovering genetic profiles in the Alzheimer's <i>continuum</i>

Natàlia Vilor‐Tejedor, Patricia Genius, Blanca Rodríguez‐Fernández et al. · Alzheimer s & Dementia · 2023 · 23 citations · Full text

Ad Biomarkers, Aging, Continuum Alfa +23

The mediating role of neuroimaging-derived biological brain age in the association between risk factors for dementia and cognitive decline in middle-aged and older individuals without cognitive impairment: a cohort study

Irene Cumplido‐Mayoral, Anna Brugulat‐Serrat, Gonzalo Sánchez‐Benavides et al. · The Lancet Healthy Longevity · 2024 · 19 citations · Full text